# ARRIVENT BIOPHARMA INC (AVBP)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AVBP/

- Reporting holders: 4
- Reported value: $53.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $21.5K | 710 | 0.0% | 6 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $16.0K | 528 | 0.0% | 4 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $15.8K | 523 | 0.0% | 10 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $545 | 18 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $53.9K |
| Q2 2026 | 162 | $1.7B |
| Q1 2026 | 141 | $989.8M |
| Q4 2025 | 122 | $817.6M |
| Q3 2025 | 106 | $715.2M |
| Q2 2025 | 97 | $732.0M |
| Q1 2025 | 82 | $539.3M |
| Q4 2024 | 80 | $757.5M |
| Q3 2024 | 68 | $612.6M |
| Q2 2024 | 54 | $404.3M |
| Q1 2024 | 53 | $389.9M |